M-3000

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameM-3000

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionForkhead box protein O1 expression modulatorsMitochondrial permeability transition pore modulatorsHepatocyte nuclear factor 4 modulators +[5]

TargetsForkhead box protein O1Hepatocyte nuclear factor 4Mitochondrial permeability transition pore +[5]

Therapy Area/IndicationsInflammationAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSyndromex

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSyndromex

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A